Clinical evaluation of a dried blood spot assay for atazanavir - Wikidata - wikimedia - TriplyDB

Clinical evaluation of a dried blood spot assay for atazanavir

Clinical evaluation of a dried blood spot assay for atazanavir

http://www.wikidata.org/entity/Q34150893

about

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.Use of dried clinical samples for storing and detecting influenza RNA.Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.

P2860

Q36554980-CF3C66D3-8E9B-46EF-871E-CF2C1DCDAEB8 Q49347647-302DC918-56BF-45FC-B3DD-1A5FEEB98C96 Q49587788-91FAAA1B-F929-4DD3-B6B1-D3A72A3AE4FB

P2860

Clinical evaluation of a dried blood spot assay for atazanavir

http://www.wikidata.org/entity/Q34150893

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clinical evaluation of a dried blood spot assay for atazanavir

@ast

Clinical evaluation of a dried blood spot assay for atazanavir

@en

Clinical evaluation of a dried blood spot assay for atazanavir

@nl

type

label

Clinical evaluation of a dried blood spot assay for atazanavir

@ast

Clinical evaluation of a dried blood spot assay for atazanavir

@en

Clinical evaluation of a dried blood spot assay for atazanavir

@nl

prefLabel

Clinical evaluation of a dried blood spot assay for atazanavir

@ast

Clinical evaluation of a dried blood spot assay for atazanavir

@en

Clinical evaluation of a dried blood spot assay for atazanavir

@nl

P1433

Q34150893-7B095CDE-AA62-41A5-845D-E950DF453600

P1476

Q34150893-C1027449-47FC-4981-A352-A2B6BD74E836

P2093

Q34150893-01F7154A-4FF2-4FE0-B564-38531F71A323

Q34150893-634578A7-0CE0-4D3C-ACBC-3193F3CA5209

Q34150893-66E4DC72-BDEC-479C-9236-757C2FCE4209

Q34150893-7BB71466-D18F-424F-A5D9-529D969FF2B7

Q34150893-F78E8CD0-A349-4BE4-B2A2-8114A333A7CF

P2860

Q34150893-1CA56391-6BB7-4AE7-A781-E570D53ABAC4

Q34150893-226EE30B-D7CC-4A59-80CD-DD1CB2EA062E

Q34150893-2B458839-4ADB-4CEF-82B6-C13E76137604

Q34150893-4F6AA453-1909-4C93-99CF-2566E984EE5A

Q34150893-607E6A59-FD96-4689-B325-873D230C2BA3

Q34150893-72846664-7740-4FF2-AF90-7E85A7A43BA2

Q34150893-74A8570D-ECCC-4732-BEF0-9DD8775D7AFF

Q34150893-7979F2BF-B5C9-489A-A8C5-79125CE2A78F

Q34150893-82D17260-26E6-4D61-B9EB-39AA1B8BE28F

Q34150893-9903D245-30B9-4884-A751-68B8F5619060

P304

Q34150893-FB594307-8F40-49DA-B0B6-1C4C4B42BDA7

P31

Q34150893-7E566727-B92B-4C9C-861A-083413D541F2

P356

Q34150893-37CE6A8E-9921-4047-BFCC-28F51655A7FD

P407

Q34150893-23B1E21D-F338-4180-B9F8-AF6383FDA10C

P433

Q34150893-F2CF43B3-ACF3-404C-9D0F-71C1512ADEB3

P478

Q34150893-35C90722-44B6-46F8-B2EB-B0EA6804C8B3

P50

Q34150893-56380453-5011-4069-9092-1501BAEC91D8

P577

Q34150893-FC55C631-9D2F-4F84-AA21-EBFDE2ED78CE

P698

Q34150893-6BA90915-A8D3-4576-B0C1-D5B7BB4073AD

P932

Q34150893-D133BF46-8DA3-4F4F-A060-B064DC70ABB3

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Clinical evaluation of a dried blood spot assay for atazanavir

@en

P2093

Brian L Robbins

http://www.w3.org/2001/XMLSchema#string

Courtney V Fletcher

http://www.w3.org/2001/XMLSchema#string

Ryan Moore

http://www.w3.org/2001/XMLSchema#string

Sarah R Nelson

http://www.w3.org/2001/XMLSchema#string

Trevor Van Schooneveld

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic drug monitoring of antiretrovirals for people with HIV

Statistical methods for assessing agreement between two methods of clinical measurement

A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.

Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules.

Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities.

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

Atazanavir: new option for treatment of HIV infection.

P304

4124-4128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00297-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Susan Swindells

P577

2010-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20660680

http://www.w3.org/2001/XMLSchema#string

P932

2944558

http://www.w3.org/2001/XMLSchema#string